Home / JUBLPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does JUBLPHARMA.NS make money? Does JUBLPHARMA.NS have pricing power? What's the Earnings Whisper? Will JUBLPHARMA.NS profit more as the business scales? What is JUBLPHARMA.NS's management track record? Is JUBLPHARMA.NS's current price justified?

Jubilant Pharmova Limited

₹938.6 -$119.50 (-11.29%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹938.2

Day Range

₹928.6₹954.9

Year Range

₹786.05₹1184.8

Market Cap

148.66B

AVG Volume

251.63K

Trailing/Forward PE

42.2/19.19

PEG ratio

-7.54

Dividend Yield

0.53%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

JUBLPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	22.29B
26 Q4	22.9B
26 Q3	21.23B
26 Q2	19.66B
26 Q1	19.01B
25 Q4	19.29B
25 Q3	18.22B
25 Q2	17.52B
25 Q1	17.32B
24 Q4	17.59B

Net Income (INR) · Q

JUBLPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	565M
26 Q4	1.19B
26 Q3	559M
26 Q2	1.2B
26 Q1	1.03B
25 Q4	1.54B
25 Q3	1.01B
25 Q2	1.03B
25 Q1	4.82B
24 Q4	-586M

Operating Income (INR) · Q

JUBLPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	1.21B
26 Q4	2.23B
26 Q3	1.69B
26 Q2	2.37B
26 Q1	6.91B
25 Q4	4.18B
25 Q3	6.87B
25 Q2	6.33B
25 Q1	6.17B
24 Q4	3.94B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Jubilant Pharmova Limited

Video analysis: JUBLPHARMA.NS

News: JUBLPHARMA.NS

Similar companies